Literature DB >> 15633216

Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.

Dong-Sheng Huang1, Ke-Zhen Shen, Jian-Feng Wei, Ting-Bo Liang, Shu-Sen Zheng, Hai-Yang Xie.   

Abstract

AIM: To evaluate the effects of NS-398, a cyclooxygenase-2 (COX-2) inhibitor, on the proliferation and apoptosis of HepG2 cells.
METHODS: The effects of NS-398 on the proliferation of HepG2 cells were evaluated by MTT. DNA fragmentation gel analysis was used to analyze the apoptotic cells. DNA ploidy and apoptotic cell percentage were calculated by flow cytometry. The expression of COX-2 and Bcl-2 mRNA was identified by competitive RT-PCR. Furthermore, expression level of Bcl-2 was detected using Western blot in HepG2 after treated with NS-398.
RESULTS: NS-398 inhibited cell proliferation and induced apoptosis of HepG2 cells in a concentration-dependent manner. DNA ploidy analysis showed that S phase cells were significantly decreased with increase of NS-398 concentration. The quiescent G0/G1 phase was accumulated with decrease of Bcl-2 mRNA. Whereas NS-398 had no effect on the expression of COX-2 mRNA, and no correlations were found between COX-2 mRNA and HepG2 cell proliferation and apoptosis induced by NS-398 (r = 0.056 and r = 0.119, respectively). Bcl-2 protein level was inhibited after treated with NS-398.
CONCLUSION: NS-398 significantly inhibits the proliferation and induces apoptosis of HepG2 cells. Mechanisms involved may be accumulation of quiescent G0/G1 phase and decrease of Bcl-2 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633216      PMCID: PMC4205402          DOI: 10.3748/wjg.v11.i2.204

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

Review 1.  Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors.

Authors:  G A Kune
Journal:  Aust N Z J Surg       Date:  2000-06

2.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

Review 3.  The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.

Authors:  G Singh-Ranger; K Mokbel
Journal:  Eur J Surg Oncol       Date:  2002-11       Impact factor: 4.424

Review 4.  Cyclooxygenase-2: a therapeutic target in angiogenesis.

Authors:  Miguel A Iñiguez; Antonio Rodríguez; Olga V Volpert; Manuel Fresno; Juan Miguel Redondo
Journal:  Trends Mol Med       Date:  2003-02       Impact factor: 11.951

5.  COX-2 and colon cancer.

Authors:  M M Taketo
Journal:  Inflamm Res       Date:  1998-10       Impact factor: 4.575

6.  Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.

Authors:  Jing Leng; Chang Han; A Jake Demetris; George K Michalopoulos; Tong Wu
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

7.  Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

Authors:  N Rioux; A Castonguay
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

Review 8.  Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.

Authors:  Edgar M Moran
Journal:  J Environ Pathol Toxicol Oncol       Date:  2002       Impact factor: 3.567

9.  Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.

Authors:  D J Elder; D E Halton; A Hague; C Paraskeva
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

Review 10.  Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.

Authors:  Suphat Subongkot; David Frame; William Leslie; Deborah Drajer
Journal:  Pharmacotherapy       Date:  2003-01       Impact factor: 4.705

View more
  9 in total

1.  Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

Authors:  Zahida Qamri; Anju Preet; Mohd W Nasser; Caroline E Bass; Gustavo Leone; Sanford H Barsky; Ramesh K Ganju
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

2.  Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells.

Authors:  Xiao-Jun Liu; Zhao-Feng Chen; Hai-Long Li; Ze-Nan Hu; Min Liu; Ai-Ping Tian; Da Zhao; Jing Wu; Yong-Ning Zhou; Liang Qiao
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

3.  Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest.

Authors:  Ji Yeon Baek; Wonhee Hur; Jin Sang Wang; Si Hyun Bae; Seung Kew Yoon
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

4.  Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells.

Authors:  Roman Paduch; Martyna Kandefer-Szerszeń
Journal:  Cancer Microenviron       Date:  2011-02-22

5.  Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma.

Authors:  Hongyan Zhu; Weili Han; Ye Gan; Qiaofeng Li; Xiaolan Li; Lanlan Shao; Dan Zhu; Hongwei Guo
Journal:  Pharmaceutics       Date:  2019-12-15       Impact factor: 6.321

6.  Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.

Authors:  Chenxi He; Fanting Kong; Xinying Zhu; Fanlei Kong; Wei Zhao; Yanling Liu; Kuixiang Wang
Journal:  Biomed Res Int       Date:  2021-11-30       Impact factor: 3.411

7.  Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.

Authors:  Xuerui Yang; Christina Chan
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

8.  Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.

Authors:  Ashok Kumar Pandurangan; Suresh Ananda Sadagopan Kumar; Prakash Dharmalingam; Sudhandiran Ganapasam
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

9.  Isolation and characterization of gallic acid and methyl gallate from the seed coats of Givotia rottleriformis Griff. and their anti-proliferative effect on human epidermoid carcinoma A431 cells.

Authors:  Samuel Kamatham; Naresh Kumar; Padmaja Gudipalli
Journal:  Toxicol Rep       Date:  2015-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.